GABAB-agonistic activity of certain baclofen homologues

Molecules

Volumn 18, Issue 9, 2013, Pages 10266-10284

  Attia, Mohamed I ^a,b   Herdeis, Claus ^b   Bräuner Osborne, Hans ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Baclofen homologues; GABA; GABAB receptor agonists; Pharmacological evaluation; Synthesis

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; DRUG DERIVATIVE;

ANALOGS AND DERIVATIVES; CELL LINE; HALOGENATION; HUMAN; IC50; STRUCTURE ACTIVITY RELATION; SYNTHESIS; ARTICLE; IC 50;

BACLOFEN; CELL LINE; GABA-B RECEPTOR AGONISTS; HALOGENATION; HUMANS; INHIBITORY CONCENTRATION 50; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84885111027     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules180910266     Document Type: Article

References (33)

1. Costantino, G.; Macchiarulo, A.; Guadix, A.E.; Pellicciari, R. QSAR and molecular modeling studies of baclofen analogues as GABAB agonists. Insights into the role of the aromatic moiety in GABAB binding and activation. J. Med. Chem. 2001, 44, 1827-1832. (Pubitemid 32852188)
2. Bernard, P.; Guedin, D.; Hibert, M. Molecular modeling of the GABA/GABAB receptor complex. J. Med. Chem. 2001, 44, 27-35. (Pubitemid 32049779)
3. Herdeis, C.; Hubmann, H.P. Synthesis of homochiral R-baclofen from S-glutamic acid. Tetrahedron: Asymmetry 1992, 3, 1213-1221.
4. Brogden, R.N.; Speight, T.M.; Avery, G.S. Baclofen: A preliminary report of its pharmacological properties and therapeutic efficacy in spasticity. Drugs 1974, 8, 1-14.
5. Tayacke, R.J.; Lingford-Hughes, A.; Reed, L.J.; Nutt, D.J. GABAB receptors in addiction and its treatment. Adv. Pharmacol. 2010, 58, 373-396.
6. Lidums, I.; Lehmann, A.; Checklin, H.; Dent, J.; Holloway, R.H. Control of transient lower esophageal sphincter relaxation. Gastroenterology 2000, 118, 7-13.
7. Yomiya, K.; Matsuo, N.; Tomiyasu, S.; Yoshimoto, T.; Tamaki, T.; Suzuki, T.; Matoba, M. Baclofen as an Adjuvant Analgesic for Cancer Pain. Am. J. Hosp. Palliat. Med. 2009, 26, 112-118.
8. Taylor, M.C.; Bates, C.P. A double-blind crossover trial of baclofen-a new treatment for the unstable bladder syndrome. Br. J. Urol. 1979, 51, 504-505. (Pubitemid 10164555)
9. Xu, F.; Peng, G.; Phan, T.; Dilip, U.; Chen, J.L.; Chernov-Rogan, T.; Zhang, X.; Grindstaff, K.; Annamalai, T.; Koller, K.; Gallop, M.A.; Wustrow, D.J. Discovery of a novel potent GABAB receptor agonist. Bioorg. Med. Chem. Lett. 2011, 21, 6582-6585.
10. Karla, R.; Ebert, B.; Thorkildsen, C.; Herdeis, C.; Johansen, T.N.; Nielsen, B.; Krogsgaard-Larsen, P. Synthesis and pharmacology of baclofen homologues, 5-amino-4-(4-chlorophenyl)pentanoic acid and the R- and S-enantiomers of 5-amino-3-(4-chlorophenyl)pentanoic acid. J. Med. Chem. 1999, 42, 2053-2059. (Pubitemid 29269639)
11. Prager, R.H.; Schafer, K. Potential GABAB receptor antagonists. X. The synthesis of further analogues of baclofen, phaclofen and saclofen. Aust. J. Chem. 1997, 50, 813-823. (Pubitemid 127595591)
12. Muhyaddin, M.; Roberts, P.J.; Woodruff, G.N. Presynaptic γ-aminobutyric acid receptors in the rat anococcygeus muscle and their antagonism by 5-aminovaleric acid. Br. J. Pharmacol. 1982, 77, 163-168. (Pubitemid 12053425)
13. Wadsworth, W.S.; Emmons, W.D. The utility of phosphonate carbanions in olefin synthesis. J. Am. Chem. Soc. 1961, 83, 1733-1738.
14. Allan, R.D.; Tran, H., Synthesis of analogues of GABA. VII&z.ast; (Z)- and (E)-4-Amino-3-(4- chlorophenyl)but-2-enoic acids as unsaturated baclofen derivatives. Aust. J. Chem. 1981, 34, 2641-2645. (Pubitemid 12161894)
15. Jones, G.; Maisey, R.F. Novel structural effects on the stereochemistry of the Wittig reaction with diethyl cyanomethylphosphonate. Chem. Commun. 1968, doi:10.1039/C19680000543.
16. Ives, D.J.G.; Sames, K. The determination of dissociation constants of monobasic acids. Part III. The strengths of some cyano-acids. J. Chem. Soc. 1943, doi:10.1039/JR9430000513.
17. Simchen, G.; Kobler, H. Synthese von Nitrilen mit Tetraalkylammoniumcyaniden. Synthesis 1975, 9, 605-607.
18. Chiefari, J.; Galanopoulos, S.; Janowski, W.K; Kerr, D.I.B.; Prager, R.H. The synthesis of phosphonobaclofen, an antagonist of baclofen. Aust. J. Chem. 1987, 40, 1511-1518.
19. Simchen, G. Eine neue Pyridinsynthese. Chem. Ber. 1970, 103, 389-397.
20. Boissonnas, R.A.; Preitner, G. Etude comparative de la scission de divers groupes de blocage de la fonction α-amino des acides amines. Helv. Chim. Acta 1953, 36, 875-886.
21. Wallach, O. Zur Kenntniss der Terpene und der ätherischen Oele. Liebigs Ann. Chem. 1900, 312, 171-210.
22. Conklin, B.R.; Farfel, Z.; Lustig, K.D.; Julius, D.; Bourne, H.R. Substitution of three amino acids switches receptor specificity of Gqα to that of Giα. Nature 1993, 363, 274-276. (Pubitemid 23158533)
23. Bräuner-Osborne, H.; Krogsgaard-Larsen, P. Functional pharmacology of cloned heterodimeric GABAB receptors expressed in mammalian cells. Br. J. Pharmacol. 1999, 128, 1370-1374.
24. Jensen, A.A.; Madsen, B.E.; Krogsgaard-Larsen, P.; Bräuner-Osborne, H. Pharmacological characterization of homobaclofen on wild type and mutant GABAB1b receptors coexpressed with the GABAB2 receptor. Eur. J. Pharmacol. 2001, 417, 177-180. (Pubitemid 32390114)
25. Kaupmann, K.; Malitschek, B.; Schuler, V.; Heid, J.; Fröstl, W.; Beck, P.; Mosbacher, J.; Bischoff, S.; Kulik, A.; Shigemoto, R.; et al. GABAB-receptor subtypes assemble into functional heteromeric complexes. Nature 1998, 396, 683-687. (Pubitemid 29003947)
26. Berthelot, P.; Vaccher, V.; Flouquet, N.; Debaert, M.; Luyckx, M.; Brunet, C. 3-Thienyl- and 3-furylaminobutyric acids. Synthesis and binding GABAB receptor studies. J. Med. Chem. 1991, 34, 2557-2560.
27. Lampe, J.W.; Chou, Y.L.; Hanna, R.G.; Di Meo, S.V.; Erhardt, P.W.; Hagedorn, A.A.; Ingebretsen, W.R.; Cantor, E. (Imidazolylphenyl)pyrrol-2-one inhibitors of cardiac cAMP phosphodiesterase. J. Med. Chem. 1993, 36, 1041-1047. (Pubitemid 23143617)
28. Malamas, M.S.; Palka, C.L. New synthesis of isoxazolidines. J. Heterocycl. Chem. 1996, 33, 475-478. (Pubitemid 126479880)
29. Blankenstein, J.; Afaltz, A. A new class of modular phosphinite oxazoline ligands: Ir-catalyzed enantioselective hydrogenation of alkenes. Angew. Chem. Int. Ed. 2001, 40, 4445-4447. (Pubitemid 33150780)
30. Kagabu, S.; Kaku, I. Preparative method for 4-aryl and 4-alkyl-2-thiolenones. Biosci. Biotech. Biochem. 1993, 57, 1899-1901.
31. Islam, S.; Ueda, I. Synthesis of allylidenetriphenylphosphoranes and arsorsnes. Dhaka Univ. J. Sci. 1999, 47, 103-107.
32. Kubo, K.; Ito, N.; Souzu, I.; Isomura, Y.; Homma, H.; Murokami, M. Nitrogen-containing heterocyclic compounds. Brit. Pat. 1588166, 1981.
33. Chahine, M.; Bennett, P.B.; George Jr., A.L.; Horn, R. Functional expression and properties of the human skeletal muscle sodium channel. Pfluegers Arch. 1994, 427, 136-142. (Pubitemid 24131564)